Bone marrow transplantation versus chemotherapy in non-hodgkin's lymphoma

John F. Seymour; Steve Flecknoe-Brown; Klaus Mross; Harry B. Burke; Stephen D. Nimer; Andrew Zelenetz; Carol Portlock; Waltraud Finckh; Adele K. Fielding; Rachel M. Pearce; Anthony H. Goldstone; Murray R. Selwyn; Leo F. Verdonck; Wim L.j. Van Putten; Anton Hagenbeek; Alexander M. Walker

doi:10.1056/NEJM199509143331111

Bone marrow transplantation versus chemotherapy in non-hodgkin's lymphoma

John F. Seymour, Steve Flecknoe-Brown, Klaus Mross, Harry B. Burke, Stephen D. Nimer, Andrew Zelenetz, Carol Portlock, Waltraud Finckh, Adele K. Fielding, Rachel M. Pearce, Anthony H. Goldstone, Murray R. Selwyn, Leo F. Verdonck, Wim L.j. Van Putten, Anton Hagenbeek, Alexander M. Walker

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Abstract

To the Editor: In their study of the efficacy of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma who respond slowly to chemotherapy, Verdonck et al. (April 20 issue)¹ used response criteria that may have influenced the outcome. A variety of criteria have been proposed to assess response in patients with lymphoma, but the most widely accepted are those ratified at the Cotswolds meeting,² which define a partial remission as “a decrease by at least 50 percent in the sum of the products of the largest perpendicular diameters of all measurable lesions.” In contrast, Verdonck et.

Original language	English
Pages (from-to)	727-730
Number of pages	4
Journal	New England Journal of Medicine
Volume	333
Issue number	11
DOIs	https://doi.org/10.1056/NEJM199509143331111
State	Published - 14 Sep 1995
Externally published	Yes

Access to Document

10.1056/NEJM199509143331111

Cite this

Seymour, J. F., Flecknoe-Brown, S., Mross, K., Burke, H. B., Nimer, S. D., Zelenetz, A., Portlock, C., Finckh, W., Fielding, A. K., Pearce, R. M., Goldstone, A. H., Selwyn, M. R., Verdonck, L. F., Van Putten, W. L. J., Hagenbeek, A., & Walker, A. M. (1995). Bone marrow transplantation versus chemotherapy in non-hodgkin's lymphoma. New England Journal of Medicine, 333(11), 727-730. https://doi.org/10.1056/NEJM199509143331111

@article{36ba2198ccda449a8b94ed08541a15c0,

title = "Bone marrow transplantation versus chemotherapy in non-hodgkin's lymphoma",

abstract = "To the Editor: In their study of the efficacy of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma who respond slowly to chemotherapy, Verdonck et al. (April 20 issue)1 used response criteria that may have influenced the outcome. A variety of criteria have been proposed to assess response in patients with lymphoma, but the most widely accepted are those ratified at the Cotswolds meeting,2 which define a partial remission as “a decrease by at least 50 percent in the sum of the products of the largest perpendicular diameters of all measurable lesions.” In contrast, Verdonck et.",

author = "Seymour, {John F.} and Steve Flecknoe-Brown and Klaus Mross and Burke, {Harry B.} and Nimer, {Stephen D.} and Andrew Zelenetz and Carol Portlock and Waltraud Finckh and Fielding, {Adele K.} and Pearce, {Rachel M.} and Goldstone, {Anthony H.} and Selwyn, {Murray R.} and Verdonck, {Leo F.} and {Van Putten}, {Wim L.j.} and Anton Hagenbeek and Walker, {Alexander M.}",

year = "1995",

month = sep,

day = "14",

doi = "10.1056/NEJM199509143331111",

language = "English",

volume = "333",

pages = "727--730",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "11",

}

Seymour, JF, Flecknoe-Brown, S, Mross, K, Burke, HB, Nimer, SD, Zelenetz, A, Portlock, C, Finckh, W, Fielding, AK, Pearce, RM, Goldstone, AH, Selwyn, MR, Verdonck, LF, Van Putten, WLJ, Hagenbeek, A & Walker, AM 1995, 'Bone marrow transplantation versus chemotherapy in non-hodgkin's lymphoma', New England Journal of Medicine, vol. 333, no. 11, pp. 727-730. https://doi.org/10.1056/NEJM199509143331111

TY - JOUR

T1 - Bone marrow transplantation versus chemotherapy in non-hodgkin's lymphoma

AU - Seymour, John F.

AU - Flecknoe-Brown, Steve

AU - Mross, Klaus

AU - Burke, Harry B.

AU - Nimer, Stephen D.

AU - Zelenetz, Andrew

AU - Portlock, Carol

AU - Finckh, Waltraud

AU - Fielding, Adele K.

AU - Pearce, Rachel M.

AU - Goldstone, Anthony H.

AU - Selwyn, Murray R.

AU - Verdonck, Leo F.

AU - Van Putten, Wim L.j.

AU - Hagenbeek, Anton

AU - Walker, Alexander M.

PY - 1995/9/14

Y1 - 1995/9/14

N2 - To the Editor: In their study of the efficacy of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma who respond slowly to chemotherapy, Verdonck et al. (April 20 issue)1 used response criteria that may have influenced the outcome. A variety of criteria have been proposed to assess response in patients with lymphoma, but the most widely accepted are those ratified at the Cotswolds meeting,2 which define a partial remission as “a decrease by at least 50 percent in the sum of the products of the largest perpendicular diameters of all measurable lesions.” In contrast, Verdonck et.

AB - To the Editor: In their study of the efficacy of high-dose chemotherapy and autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma who respond slowly to chemotherapy, Verdonck et al. (April 20 issue)1 used response criteria that may have influenced the outcome. A variety of criteria have been proposed to assess response in patients with lymphoma, but the most widely accepted are those ratified at the Cotswolds meeting,2 which define a partial remission as “a decrease by at least 50 percent in the sum of the products of the largest perpendicular diameters of all measurable lesions.” In contrast, Verdonck et.

UR - http://www.scopus.com/inward/record.url?scp=0029643627&partnerID=8YFLogxK

U2 - 10.1056/NEJM199509143331111

DO - 10.1056/NEJM199509143331111

M3 - Letter

C2 - 7637755

AN - SCOPUS:0029643627

SN - 0028-4793

VL - 333

SP - 727

EP - 730

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 11

ER -

Bone marrow transplantation versus chemotherapy in non-hodgkin's lymphoma

Abstract

Access to Document

Fingerprint

Cite this